Contineum Therapeutics
Clinical trials sponsored by Contineum Therapeutics, explained in plain language.
-
New MS pill tested as add-on therapy in major trial
Disease control CompletedThis study tested whether adding an oral medication called PIPE-307 to existing multiple sclerosis treatments could help control the disease. About 182 adults with relapsing-remitting MS took either one of two doses of PIPE-307 or a placebo pill for about 30 weeks. Researchers me…
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Early trial tests new pill for common chronic pain
Symptom relief CompletedThis study tested a new oral medication, PIPE-791, to see if it is safe and can help reduce pain in adults with long-term osteoarthritis pain or chronic low back pain. In this small, early-stage trial, 43 participants took the drug or a placebo for 4-week periods to compare effec…
Phase: PHASE1 • Sponsor: Contineum Therapeutics • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC